Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1950 1
1953 3
1955 1
1956 3
1957 1
1958 3
1959 5
1961 1
1962 5
1964 2
1965 1
1966 13
1967 18
1969 13
1970 4
1971 6
1972 2
1973 1
1974 5
1978 15
1979 6
1981 3
1982 6
1983 3
1984 2
1985 9
1986 7
1987 7
1988 7
1989 1
1990 8
1991 8
1992 7
1993 3
1994 2
1995 6
1996 1
1997 4
1998 2
1999 3
2001 1
2007 1
2009 3
2010 1
2012 1
2013 1
2014 2
2015 1
2016 1
2020 4
2021 1
2022 1
2023 2
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Results by year

Filters applied: . Clear all
Page 1
A 24-week prospective, multicenter, real-world study on eptinezumab's effectiveness and safety in migraine prevention (EMBRACE II).
Barbanti P, Aurilia C, Egeo G, Doretti A, d'Onofrio F, Scatena P, Rinalduzzi S, Vinciguerra L, Sansone M, Vecchio R, Drago V, Viticchi G, Bartolini M, Ranieri A, Bandettini di Poggio M, Baldisseri F, Mascarella D, Brusaferri F, Caputi L, Messina S, Autunno M, Valenza A, Orlando B, Distefano M, Borrello L, Pistoia F, Camarda C, Saporito G, Querzola G, Torelli P, Salerno A, Gragnani F, Petolicchio B, Carnevale A, Messina R, Filippi M, Tavani S, Fiorentini G, Bonassi S, Cevoli S, Mannocci A; Italian Migraine Registry (I-GRAINE) study group. Barbanti P, et al. J Neurol. 2025 May 7;272(6):382. doi: 10.1007/s00415-025-13095-z. J Neurol. 2025. PMID: 40332560 Free PMC article.
GIANT: a prospective, multicenter, real-world study on the effectiveness, safety, and tolerability of atogepant in migraine patients with multiple therapeutic failures.
Barbanti P, Egeo G, Pistoia F, Aurilia C, Scatena P, Rinalduzzi S, Strumia S, Salerno A, Frediani F, Galli A, Autunno M, Di Clemente L, Zucco M, Albanese M, Bono F, Bruno P, Borrello L, Messina S, Doretti A, Ranieri A, Camarda C, Vecchio R, Drago V, Fiorentini G, Tomino C, Bonassi S, Torelli P, Mannocci A; Italian Migraine Registry (I-GRAINE) study group. Barbanti P, et al. J Headache Pain. 2025 May 19;26(1):122. doi: 10.1186/s10194-025-02068-2. J Headache Pain. 2025. PMID: 40389834 Free PMC article.
[Electrocardiography 1991].
Cherchi A. Cherchi A. Cardiologia. 1992 Jan;37(1):5-12. Cardiologia. 1992. PMID: 1533817 Italian. No abstract available.
[ENDOCARDIAL FIBROELASTOSIS].
CHERCHI A, MONTI G. CHERCHI A, et al. Recenti Prog Med. 1964 Apr;36:227-87. Recenti Prog Med. 1964. PMID: 14166779 Review. Italian. No abstract available.
Burden and attitude to resistant and refractory migraine: a survey from the European Headache Federation with the endorsement of the European Migraine & Headache Alliance.
Sacco S, Lampl C, Maassen van den Brink A, Caponnetto V, Braschinsky M, Ducros A, Little P, Pozo-Rosich P, Reuter U, Ruiz de la Torre E, Sanchez Del Rio M, Sinclair AJ, Martelletti P, Katsarava Z; Burden and Attitude to Resistant and Refractory (BARR) Study Group. Sacco S, et al. J Headache Pain. 2021 May 18;22(1):39. doi: 10.1186/s10194-021-01252-4. J Headache Pain. 2021. PMID: 34006218 Free PMC article.
219 results